His main research concerns Mycobacterium tuberculosis, Tuberculosis, Genetics, Restriction fragment length polymorphism and Mycobacterium tuberculosis complex. The concepts of his Mycobacterium tuberculosis study are interwoven with issues in Phylogenetic tree, Microbiology, Sputum, Locus and Polymerase chain reaction. His Microbiology study integrates concerns from other disciplines, such as Phagolysosome and Mycobacterium.
His Tuberculosis research incorporates elements of Internal medicine, Epidemiology, Virology, Immunology and Drug resistance. His Restriction fragment length polymorphism research is multidisciplinary, relying on both Typing and DNA profiling. His Mycobacterium tuberculosis complex research includes themes of Population genetics, Direct repeat, Chromosomal region, Phylogenetics and Multilocus sequence typing.
His primary scientific interests are in Mycobacterium tuberculosis, Tuberculosis, Microbiology, Genotype and Genetics. He is involved in the study of Mycobacterium tuberculosis that focuses on Mycobacterium tuberculosis complex in particular. His studies in Tuberculosis integrate themes in fields like Internal medicine, Immunology and Multiple drug resistance, Drug resistance.
His research investigates the connection between Drug resistance and topics such as Pharmacology that intersect with issues in Antibiotics. His Microbiology research also works with subjects such as
Dick van Soolingen mainly focuses on Tuberculosis, Mycobacterium tuberculosis, Drug resistance, Genetics and Whole genome sequencing. Dick van Soolingen performs integrative study on Tuberculosis and Transmission. His Mycobacterium tuberculosis research is multidisciplinary, relying on both Lineage, Multiple drug resistance and Genotype.
His Genotype study deals with Virology intersecting with Disease cluster, Capreomycin and Drug susceptibility. His Whole genome sequencing study also includes fields such as
Dick van Soolingen mostly deals with Tuberculosis, Mycobacterium tuberculosis, Genetics, Whole genome sequencing and Mycobacterium tuberculosis complex. Dick van Soolingen interconnects Internal medicine, Antibiotic resistance and Drug resistance in the investigation of issues within Tuberculosis. His Drug resistance research focuses on subjects like Isoniazid, which are linked to Disease.
In his study, Capreomycin, Disease cluster and Multidrug-Resistant Mycobacterium tuberculosis is inextricably linked to Virology, which falls within the broad field of Mycobacterium tuberculosis. The various areas that Dick van Soolingen examines in his Whole genome sequencing study include DNA profiling, Genetic epidemiology, Concordance, Genotyping and Molecular epidemiology. His Mycobacterium tuberculosis complex research is multidisciplinary, incorporating elements of SNP, Subspecies, Zoonosis and Clade.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Mycobacterium tuberculosis complex genetic diversity: mining the fourth international spoligotyping database (SpolDB4) for classification, population genetics and epidemiology
Karine Brudey;Jeffrey R Driscoll;Leen Rigouts;Wolfgang M Prodinger.
BMC Microbiology (2006)
Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis
Neel R Gandhi;Paul Nunn;Keertan Dheda;Keertan Dheda;H Simon Schaaf.
The Lancet (2010)
Automated High-Throughput Genotyping for Study of Global Epidemiology of Mycobacterium tuberculosis Based on Mycobacterial Interspersed Repetitive Units
Philip Supply;Sarah Lesjean;Evgueni Savine;Kristin Kremer.
Journal of Clinical Microbiology (2001)
The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative study
Wouter Hoefsloot;Jakko Van Ingen;Claire Andrejak;Kristian Ängeby.
European Respiratory Journal (2013)
The influence of host and bacterial genotype on the development of disseminated disease with Mycobacterium tuberculosis
Maxine Caws;Maxine Caws;Guy Thwaites;Sarah Dunstan;Sarah Dunstan;Thomas R. Hawn.
PLOS Pathogens (2008)
Origin, Spread and Demography of the Mycobacterium tuberculosis Complex
Thierry Wirth;Falk Hildebrand;Caroline Allix-Béguec;Florian Wölbeling.
PLOS Pathogens (2008)
Nature of DNA polymorphism in the direct repeat cluster of Mycobacterium tuberculosis; application for strain differentiation by a novel typing method
Peter M. A. Groenen;Annelies E. Bunschoten;Dick van Soolingen;Jan D. A. van Errtbden.
Molecular Microbiology (1993)
Epidemiology of antituberculosis drug resistance 2002–07: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance
Abigail Wright;Matteo Zignol;Armand Van Deun;Armand Van Deun;Dennis Falzon.
The Lancet (2009)
Characterization of the Catalase-Peroxidase Gene (katG) and inhA Locus in Isoniazid-Resistant and -Susceptible Strains of Mycobacterium tuberculosis by Automated DNA Sequencing: Restricted Array of Mutations Associated with Drug Resistance
James M. Musser;Vivek Kapur;Diana L. Williams;Barry N. Kreiswirth.
The Journal of Infectious Diseases (1996)
Molecular evidence to support a proposal to reserve the designation Mycobacterium avium subsp. avium for bird-type isolates and 'M. avium subsp. hominissuis' for the human/porcine type of M. avium.
Wouter Mijs;Petra de Haas;Rudi Rossau;Tridia Van der Laan.
International Journal of Systematic and Evolutionary Microbiology (2002)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: